-

Company Profile for Anova Enterprises, Inc.

--(BUSINESS WIRE)--Anova is a technology company bringing participants in the clinical research process together to speed promising new treatments to market, at reduced cost and for a larger number of patients. We kickstart the development of new treatments through standardization and automation as no one else can do.

Company:

Anova Enterprises, Inc.

 

 

Headquarters Address:

One Arlington Executive Center

 

3400 West Stonegate Boulevard, Suite 101

 

Arlington Heights, IL 60005

 

 

Main Telephone:

224-218-2408

 

 

Website:

www.anovaevidence.com

 

 

Type of Organization:

Private

 

 

Industry:

Health

 

 

Key Executives:

President: Martin Walsh

 

CEO: Chris Beardmore

 

 

Investor Relations

 

Contact:

Martin Walsh

Phone:

(224) 218-2408

Email:

martin@anovaevidence.com

 

 

Public Relations

 

Contact:

Louise Rayner

Phone:

(224) 218-2408

Email:

louise@anovaevidence.com

 

Industry:

Anova Enterprises, Inc.

Details
Headquarters: Chicago, ILLINOIS
CEO: Christopher Beardmore
Employees: 21-50
Organization: PRI
Release Versions
English
Hashtags
#anova
#clinicaltrials
#compassionateuse
Social Media Profiles
Anova
Anova
Anova
More News From Anova Enterprises, Inc.

Anova Expands Platform With Launch of Next-Generation eTMF Solution for Sponsors, CROs, and Research Sites

LONDON & CHICAGO--(BUSINESS WIRE)--Anova Enterprises, Inc. (Anova), a leading technology-enabled Clinical Research Organization (CRO) focused on accelerating and reducing the cost of clinical development, today announced the launch of its next-generation electronic Trial Master File (eTMF) platform — a unified study document management solution designed to eliminate redundant tasks and administrative burden, improve compliance, and create frictionless collaboration between sponsors, CROs, and r...

Anova and Nouveau Biosciences Announce Partnership to Deliver Clinical Trials of Kromastat for the Treatment of Relapsed or Refractory Cutaneous and Peripheral T-Cell Lymphoma

LONDON & CHICAGO--(BUSINESS WIRE)--Anova Enterprises, Inc. (Anova), a technology enabled CRO dedicated to accelerating promising treatments, today announced its partnership with Nouveau Biosciences, Inc. to conduct cancer focused clinical trials for their lead asset Kromastat. Nouveau Biosciences is a biotechnology company pioneering novel targeted nanomedicines to improve cancer therapy. Nouveau Biosciences has developed a proprietary drug discovery technology coupled to a polymer-based nanoch...

Five Hundredth Urology Research Site Joins Anova’s Global Urology Research Network

LONDON & CHICAGO--(BUSINESS WIRE)--Anova Enterprises, Inc. (Anova), a leading technology-enabled Clinical Research Organization (CRO) today announced the expansion of a virtual urology research network delivered via its AnovaOS® platform. This network of quality confirmed urology research sites has reached a major milestone with the onboarding of its 500th site. Anova’s proprietary clinical research technology platform, AnovaOS®‚ facilitates seamless collaboration, streamlined study operations,...
Back to Newsroom